The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
NYS Entity Status
NYS Filing Date
MARCH 25, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - BLUE OCEAN FOOD CORP
AROUND THE WEB
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
- Restaurant Review: A New Kind of Sichuan Restaurant for New York
By PETE WELLS - Tuesday Aug 1, 2017
In downtown Flushing, Queens, Guan Fu Sichuan shows off the rich variety of flavors beyond the familiar blast of chiles.
- NY State Comptroller Helps Stakeholders Take Action on Climate and Food
By Marian Conway - Thursday Jul 13, 2017
The changing environment, specifically climate change, is becoming a major piece of the global economic puzzle. Decisions are now increasingly based not just on the bottom line, but on the Earth’s future.
- Blue Apron slashes its IPO price by a third
By Reuters - Wednesday Jun 28, 2017
Online meal-kit company Blue Apron Holdings slashed its valuation expectations by a third amid growing concerns about the potential impact from Amazon’s deal to buy Whole Foods. The company said on Wednesday it expects its IPO to be priced between $10 and $11 per share, down from its previous expectation of $15 to $17. The...
- Blue Apron shares hit as Amazon files for meal-kit trademark
By Lisa Fickenscher - Monday Jul 17, 2017
Amazon is clobbering Blue Apron’s stock again. The meal-kit delivery service — which was forced to slash its IPO price by a third last month on worries about a threat from Amazon’s merger with Whole Foods — saw its shares hit again Monday on news that Amazon is planning to launch its own meal-kit delivery...
- Novel leukemia treatment could be 1st US gene therapy
By Associated Press - Thursday Jul 13, 2017
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...